(Q71483455)
Statements
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice (English)
Borrelia burgdorferi
1 reference
Keane-Myers A
Maliszewski CR
Finkelman FD
1 April 1996